Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.330
+0.180 (5.71%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Sana Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 889 | 1,084 | 364 | 804 | 750 | 2,833 | |
| Market Cap Growth | 30.07% | 197.89% | -54.75% | 7.21% | -73.52% | - | |
| Enterprise Value | 837 | 1,021 | 261 | 633 | 350 | 2,066 | |
| Last Close Price | 3.33 | 4.07 | 1.63 | 4.08 | 3.95 | 15.48 | |
| PB Ratio | 5.52 | 6.74 | 1.45 | 2.80 | 1.50 | 3.89 | |
| P/TBV Ratio | - | - | 7.18 | 9.17 | 2.51 | 5.36 | |
| Debt / Equity Ratio | 0.54 | 0.54 | 0.38 | 0.36 | 0.22 | 0.15 | |
| Net Debt / Equity Ratio | -0.32 | -0.32 | -0.23 | -0.35 | -0.65 | -0.87 | |
| Net Debt / EBITDA Ratio | 0.29 | 0.29 | 0.23 | 0.33 | 1.27 | 2.03 | |
| Net Debt / FCF Ratio | 0.36 | 0.36 | 0.23 | 0.37 | 1.05 | 2.26 | |
| Quick Ratio | 1.76 | 1.76 | 3.36 | 3.18 | 3.80 | 5.55 | |
| Current Ratio | 1.89 | 1.89 | 3.54 | 3.31 | 3.99 | 5.62 | |
| Return on Equity (ROE) | -118.70% | -118.70% | -99.17% | -72.00% | -43.90% | -61.36% | |
| Return on Assets (ROA) | -26.00% | -26.00% | -31.82% | -29.44% | -17.38% | -21.85% | |
| Return on Capital Employed (ROCE) | -56.50% | -56.50% | -59.60% | -65.30% | -38.20% | -31.60% | |
| Earnings Yield | -27.48% | -22.52% | -73.30% | -35.22% | -35.92% | -12.56% | |
| FCF Yield | -16.29% | -13.35% | -70.50% | -34.02% | -41.45% | -9.91% | |
| Buyback Yield / Dilution | -9.68% | -9.68% | -18.68% | -3.29% | -13.16% | -1178.88% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.